Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colon Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Testing effectiveness (Phase 2)Looking for participantsNCT07147231
What this trial is testing

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

Who this might be right for
Metastatic Colorectal AdenocarcinomaRefractory Colorectal AdenocarcinomaStage III Colorectal Cancer AJCC v8+2 more
National Cancer Institute (NCI) 86
Not applicableStudy completedNCT01720706
What this trial is testing

Thermal Ablation in Larger Liver and Kidney Tumours

Who this might be right for
Liver and Kidney Tumours
University Health Network, Toronto 12
Not applicableUnknownNCT05718349
What this trial is testing

FGF19 in Obstructive Cholestasis: "Unveil the Signal"

Who this might be right for
CholestasisIcterusCholangiocarcinoma+2 more
Nicole Hildebrand 81
Large-scale testing (Phase 3)Active Not RecruitingNCT04793958
What this trial is testing

Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)

Who this might be right for
Advanced Colorectal CancerMetastatic Colorectal Cancer
Mirati Therapeutics Inc. 461
Testing effectiveness (Phase 2)UnknownNCT00007826
What this trial is testing

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Onyvax
Testing effectiveness (Phase 2)Study completedNCT00003220
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT01528878
What this trial is testing

Safety, Efficacy, and Dosing of Stereotactic Radiosurgery for Hepato-cellular Carc/Colo-rectal Liver Metastases

Who this might be right for
Liver NeoplasmsColonic NeoplasmsMetastatic Cancer to Liver
UNC Lineberger Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00265850
What this trial is testing

Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 2,334
Early research (Phase 1)Study completedNCT00656123
What this trial is testing

Study of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Testing effectiveness (Phase 2)Ended earlyNCT02173990
What this trial is testing

Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US (PULSAR).

Who this might be right for
Metastatic Colorectal Cancer
Centre Oscar Lambret 40
Large-scale testing (Phase 3)Study completedNCT00265824
What this trial is testing

Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 700
Large-scale testing (Phase 3)UnknownNCT00182715
What this trial is testing

Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Velindre NHS Trust 2,421
Large-scale testing (Phase 3)Ended earlyNCT00023868
What this trial is testing

Combination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)

Who this might be right for
Colorectal CancerMetastatic Cancer
American College of Radiology Imaging Network
Early research (Phase 1)Looking for participantsNCT06411691
What this trial is testing

KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer

Who this might be right for
Colorectal CancerPancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 54
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Early research (Phase 1)Looking for participantsNCT06040541
What this trial is testing

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 604
Testing effectiveness (Phase 2)Active Not RecruitingNCT04616183
What this trial is testing

LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+28 more
M.D. Anderson Cancer Center 46
Not applicableUnknownNCT02979470
What this trial is testing

Study of Blood Components as Probable Prognostic and Predictive Markers of Response to Treatment in Advanced Colon and Rectal Cancers

Who this might be right for
Colon Cancer Stage IIbRectum Cancer, AdenocarcinomaColon Cancer Stage IIIa+2 more
AC Camargo Cancer Center 100
Testing effectiveness (Phase 2)WithdrawnNCT03982173
What this trial is testing

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Who this might be right for
Metastatic Colorectal CancerTriple Negative Breast CancerProstate Adenocarcinoma+2 more
Gustave Roussy, Cancer Campus, Grand Paris
Next Page